Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Water Street: Finding a Middle-Market PE Niche

This article was originally published in Start Up

Executive Summary

While many private equity investors appear to be focusing on the high and low ends of the device investment spectrum, Chicago-based Water Street Healthcare Partners is a firm carving its niche out of middle-market opportunities.

You may also be interested in...



Orthofix Spin-Out Presents Another Opportunity For Private Equity

A handful of orthopedic companies are combating sluggish markets by sticking with what they know best – selling hip and knee implants. This has created a robust opportunity for private equity investors looking to build businesses in orthopedics peripheral markets. Health care-focused PE firm Water Street Healthcare Partners last month made the latest move by agreeing to buy Breg Inc., the sports medicine business of Orthofix International NV, for $157.5 million or 1.5 times 2011 revenues of $103 million.

Devices Pique Private Equity's Interest

The spate of recent carve-outs from Boston Scientific has private equity and venture capital investors hungry for similar deals across the industry. But device companies don't seem to be serving much up.

Devices Pique Private Equity's Interest

The spate of recent carve-outs from Boston Scientific has private equity and venture capital investors hungry for similar deals across the industry. But device companies don't seem to be serving much up.

Related Content

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037528

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel